Dr. Amir Ali Salemi is the Founder and CEO of JTA International Holding and is the Chairman of JTA Subsidiary Holding Companies. He was appointed as the CEO of JTA in 2010. He holds a PhD in Strategic Management. He has many years of experience and deep expertise in leading strategic partnerships and investments, setting benchmarks for the larger markets to follow. He was awarded the excellence in business management award, the successful leader award and excellence in quality management award in 2021 from world confederation of businesses. Dr. Amir Ali Salemi foresight and persistence played a significant role in overcoming the pandemic-related challenges. He was also selected as Entrepreneur of the Year for Asia in 2021 by Global Banking and Finance Review. Dr. Amir Ali Salemi is a distinguished business executive known for his exceptional leadership and entrepreneurial skills. Starting his career at the age of 16 while still in school, he focused on assisting youth with cultural development and entrepreneurial skills. During his university years, Amir managed small companies, laying the groundwork for his extensive business experience. Rapidly excelling, he assumed various management positions due to his outstanding performance and drive for excellence. Amir's strategic vision, innovative ideas, and unwavering commitment to exceptional results have underpinned his expertise in the industry. Today, he is a prominent figure in the business world, inspiring and mentoring young entrepreneurs globally. During the covid- 19 Pandemic, he led JTA to be recognized as the Inspirational Company of 2021 by the World Confederation of Businesses due to its unmatched growth.

He graduated from “Pierre et Marie Curie University” (Paris VI) and the Pasteur Institute in Paris. In addition to holding three doctorates and PhD in Industrial Pharmacy, Biotechnology, and Vaccination, he has authored over twenty-five original studies and filed four patents for novel drugs that treat Colon Cancer, Bladder Cancer, and all forms of Chronic Inflammation. He has over 35 years of expertise in pharmaceutical manufacturing and healthcare marketing in the Middle East, Europe, South Korea, China, India, and South American countries.

He has a Post-Doc in Global Small and Medium Enterprises Management from FHM, Germany and has a PhD in Engineering Management and DBA in Strategic Management. He has over than 30 years of deep expertise in leading international strategic partnerships and managing well-known construction company, investment holding and multidisciplinary companies. He is the official representative of the London Institute of Skill and Development (LISD) in the Middle East in the field of consulting and training of SMEs and has published many books and articles in the field of management and business and is a Member of the editorial board of scientific journals.